Clinical Trial Management System Market by End User (Pharma & Biopharmaceutical Co., Medical Device Co., CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Services) - Global Forecast to 2022

Date: January 18, 2018
Pages: 266
Price:
US$ 5,650.00
License [?]:
Publisher: MarketsandMarkets
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: CF2D9EBFE18EN
Leaflet:

Download PDF Leaflet

Clinical Trial Management System Market by End User (Pharma & Biopharmaceutical Co., Medical Device Co., CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Services) - Global Forecast to 2022
“The clinical trial management system (CTMS) market is projected to grow at a CAGR of 12.6% during the forecast period”

The global CTMS market is projected to reach USD 1,065.6 million by 2022 from USD 590.0 million in 2017, at a CAGR of 12.6%. The major factors driving the growth of the CTMS market include the increasing partnerships between biopharma companies and CROs, rising number of ongoing clinical trials, rising government funding & grants to support clinical trials, availability of advanced CTMS solutions, and growing customer base for CTMS solutions. However, the major market restraints are limited awareness among researchers about the advantages of CTMS solutions and budget constraints faced by the emerging countries.

“The cloud-based CTMS segment is expected to grow at the highest rate during the forecast period”

On the basis of delivery mode, the global CTMS market is segmented into web-based (on-demand), licensed enterprise (on premise), and cloud-based (SaaS) segments. The cloud-based (SaaS) segment is estimated to witness the highest growth during the forecast period, primarily due to the rising adoption of cloud-based solutions in medical research studies owing to various benefits offered by them such as low cost, high security, privacy, and easy accessibility from any device.

“Software segment accounted for the largest share of the CTMS market by component”

On the basis of component, the CTMS market is segmented into software and services. The software segment is expected to have the largest share of the market. This is mainly attributed to the fierce competition in the pharmaceutical industry to introduce cost-effective novel drugs in the market, increased adoption of CTMS due to advantages provided by the same among various end users, and increasing number of clinical trials.

“The APAC market is expected to grow at the highest CAGR during the forecast period”

Geographically, the CTMS market is segmented into North America, Europe, Asia Pacific (APAC), and the rest of the world. The APAC market is expected to register the highest growth rate during the forecast period. Increasing government funding to support clinical trials, the presence of less stringent regulatory guidelines as compared to developed nations, a large patient base, faster rate of patient recruitment for clinical trials than mature nations, low operating costs for conducting clinical trials, shortage of trial volunteers in Europe and North America, and the growing number of pharmaceutical companies and CROs are fueling the growth of the APAC CTMS market.

Breakdown of supply-side primary interviews:
  • By Company Type - Tier 1 – 25%, Tier 2 – 30% and Tier 3 – 45%
  • By Designation - C-level – 26%, Director level – 30%, Others – 44%
  • By Region - North America - 34%, Europe – 26%, APAC – 23%, RoW – 17%
The major players in the market included are Oracle (US), Medidata Solutions (US), PAREXEL (US), Bioclinica (US), Bio-Optronics (US), and IBM (US).

Research Coverage

This report studies the CTMS market based on type, delivery mode, component, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Reasons to Buy the Report:

This report focuses on various levels of analysis—industry trends, market ranking of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the CTMS market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKETS SCOPE
  1.3.1 MARKETS COVERED
  1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED
1.5 MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
  2.1.1 SECONDARY DATA
  2.1.2 PRIMARY DATA
2.2 MARKET SIZE ESTIMATION
  2.2.1 TOP-DOWN APPROACH
  2.2.2 BOTTOM-UP APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 CTMS: MARKET OVERVIEW (2017–2022)
4.2 GLOBAL CTMS MARKET, BY COMPONENT, 2017 VS. 2022
4.3 GLOBAL CTMS MARKET, BY TYPE, 2017 VS. 2022
4.4 GLOBAL CTMS MARKET, BY END-USER AND MODE OF DELIVERY (2017)
4.5 CTMS MARKET BY COUNTRY, 2017

5 MARKET OVERVIEW

5.1 DRIVERS
5.2 RESTRAINTS
5.3 OPPORTUNITIES
5.4 CHALLENGES
5.5 KEY INDUSTRY TRENDS

6 CTMS MARKET, BY TYPE

6.1 INTRODUCTION
6.2 ENTERPRISE CTMS
6.3 SITE CTMS

7 CTMS MARKET, BY DELIVERY MODE

7.1 INTRODUCTION
7.2 WEB-BASED (HOSTED) CTMS
7.3 LICENSED ENTERPRISE (ON PREMISE) CTMS
7.4 CLOUD-BASED (SAAS) CTMS

8 CTMS MARKET, BY COMPONENT

8.1 INTRODUCTION
8.2 SOFTWARES
8.3 SERVICES

9 CTMS MARKET, BY END USER

9.1 INTRODUCTION
9.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
  9.2.1 LARGE PHARMACEUTICAL COMPANIES
  9.2.2 MID-SMALL PHARMACEUTICAL COMPANIES
9.3 CONTRACT RESEARCH ORGANIZATIONS
9.4 MEDICAL DEVICE COMPANIES
9.5 OTHER END USERS

10 CTMS MARKET, BY REGION

10.1 INTRODUCTION
10.2 NORTH AMERICA
  10.2.1 US
  10.2.1 CANADA
10.3 EUROPE
  10.3.1 GERMANY
  10.3.2 UK
  10.3.3 FRANCE
  10.3.4 REST OF EUROPE (ROE)
10.4 ASIA PACIFIC
  10.4.1 CHINA
  10.4.2 JAPAN
  10.4.3 INDIA
  10.4.4 REST OF ASIA PACIFIC
10.5 REST OF THE WORLD (ROW)

11 COMPETITIVE LANDSCAPE

11.1 OVERVIEW
11.2 CTMS MARKET SHARE ANALYSIS, BY KEY PLAYERS (2016)
11.3 COMPETITIVE SCENARIO AND TRENDS
  11.3.1 PRODUCT LAUNCHES AND ENHANCEMENTS (2014–2017)
  11.3.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2014–2017)
  11.3.3 MARKET EXPANSIONS (2014–2017)
  11.3.4 MERGERS AND ACQUISITIONS (2014–2017)

*Top 15 companies analyzed for this studies are - Oracle (US), Medidata Solutions (US), PAREXEL (US), Bioclinica (US), Bio-Optronics (US), IBM (US), DATATRAK (US), Veeva Systems (US), DSG (US), MasterControl (US), ERT (US), Forte Research Systems (US), MedNet Solutions (US), ArisGlobal (US), and DZS Software Solutions (US).

12 COMPANY PROFILES

(Introduction, Products & Services, Financial Snapshots, Developments, MnM View)*

12.1 ORACLE
12.2 MEDIDATA SOLUTIONS
12.3 PAREXEL
12.4 BIOCLINICA
12.5 BIO-OPTRONICS
12.6 IBM
12.7 DATATRAK
12.8 VEEVA SYSTEMS
12.9 DSG
12.10 MASTERCONTROL
12.11 ERT
12.12 FORTE RESEARCH SYSTEMS
12.13 MEDNET SOLUTIONS
12.14 ARISGLOBAL
12.15 DZS SOFTWARE SOLUTIONS

*Details on MarketsandMarkets view, Introduction, Product & Services, New Developments might not be captured in case of unlisted companies.

13 APPENDIX

13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
13.6 AUTHORS DETAILS

LIST OF TABLES

Table 1 LIST OF PARTNERSHIPS BETWEEN BIOPHARMA COMPANIES AND CROS
Table 2 GLOBAL CTMS MARKET, BY TYPE, 2017–2022 (USD MILLION)
Table 3 CTMS MARKET FOR ENTERPRISE CTMS, BY REGION, 2017–2022 (USD MILLION)
Table 4 CTMS MARKET FOR SITE CTMS, BY REGION, 2017–2022 (USD MILLION)
Table 5 GLOBAL CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
Table 6 WEB-BASED (ON-DEMAND) CTMS MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 7 LICENSED ENTERPRISE (ON-PREMISE) CTMS MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 8 CLOUD-BASED (SAAS) CTMS MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 9 GLOBAL CTMS MARKET, BY COMPONENT, 2017–2022 (USD MILLION)
Table –10 CTMS MARKET FOR SOFTWARE BY REGION, 2017–2022 (USD MILLION)
Table 11 CTMS MARKET FOR SERVICES BY REGION, 2017–2022 (USD MILLION)
Table 12 GLOBAL CTMS MARKET, BY END USER, 2017–2022 (USD MILLION)
Table 13 CTMS MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES BY REGION, 2017–2022 (USD MILLION)
Table 14 CTMS MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES BY TYPE, 2017–2022 (USD MILLION)
Table 15 CTMS MARKET FOR LARGE PHARMACEUTICAL COMPANIES BY REGION, 2017–2022 (USD MILLION)
Table 16 CTMS MARKET FOR SMALL-MID SIZED PHARAMCEUTICAL COMPANIES BY REGION, 2017–2022 (USD MILLION)
Table 17 STRATEGIC ALLIANCES BETWEEN CROS AND PHARMA COMPANIES (2011–2015)
Table 18 CTMS MARKET FOR CRO BY REGION, 2017–2022 (USD MILLION)
Table 19 CTMS MARKET FOR MEDICAL DEVICE COMPANIES BY REGION, 2017–2022 (USD MILLION)
Table 20 CTMS MARKET FOR OTHER END USERS BY REGION, 2017–2022 (USD MILLION)
Table 21 CTMS MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 22 NORTH AMERICA: CTMS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 23 NORTH AMERICA: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
Table 24 NORTH AMERICA: CTMS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 25 NORTH AMERICA: CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
Table 26 NORTH AMERICA: CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 27 NORTH AMERICA: PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 28 US: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
Table 29 US: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
Table 30 US: CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
Table 31 US: CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 32 CANADA: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
Table 33 CANADA: CTMS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 34 CANADA: CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
Table 35 CANADA: CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 36 EUROPE: CTMS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 37 EUROPE: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
Table 38 EUROPE: CTMS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 39 EUROPE: CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
Table 40 EUROPE: CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 41 EUROPE: PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 42 GERMANY: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
Table 43 GERMANY: CTMS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 44 GERMANY: CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
Table 45 GERMANY: CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 46 UK: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
Table 47 UK: CTMS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 48 UK: CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
Table 49 UK: CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 50 FRANCE: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
Table 51 FRANCE: CTMS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 52 FRANCE: CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
Table 53 FRANCE: CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 54 ROE: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
Table 55 ROE: CTMS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 56 ROE: CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
Table 57 ROE: CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 58 APAC: CTMS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 59 APAC: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
Table 60 APAC: CTMS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 61 APAC: CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
Table 62 APAC: CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 63 APAC: PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 64 CHINA: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
Table 65 CHINA: CTMS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 66 CHINA: CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
Table 67 CHINA: CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 68 JAPAN: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
Table 69 JAPAN: CTMS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 70 JAPAN: CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
Table 71 JAPAN: CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 72 INDIA: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
Table 73 INDIA: CTMS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 74 INDIA: CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
Table 75 INDIA: CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 76 ROAPAC: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION))
Table 77 ROAPAC: CTMS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 78 ROAPAC: CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION))
Table 79 ROAPAC: CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 80 ROW: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
Table 81 ROW: CTMS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 82 ROW: CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
Table 83 ROW: CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 84 ROW: PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 85 PRODUCT LAUNCHES AND ENHANCEMENTS (2014–2017)
Table 86 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2014–2017)
Table 87 MARKET EXPANSIONS (2014–2017)
Table 88 MERGERS AND ACQUISITIONS (2014–2017)

LIST OF FIGURES

Figure 1 RESEARCH DESIGN
Figure 2 BREAKDOWN OF PRIMARIES
Figure 3 ENTERPRISE CTMS SEGMENT TO HOLD THE LARGEST SHARE OF THE CTMS MARKET IN 2017
Figure 4 SOFTWARE SEGMENT TO HOLD THE LARGEST SHARE IN THE CTMS MARKET DURING 2017–2022
Figure 5 WEB-BASED CTMS SEGMENT TO HOLD THE LARGEST SHARE IN THE CTMS MARKET DURING THE FORECAST PERIOD
Figure 6 CTMS MARKET, BY END USER, 2017 VS. 2022
Figure 7 NORTH AMERICA TO DOMINATE THE GLOBAL CTMS MARKET DURING THE FORECAST PERIOD
Figure 8 RISING NUMBER OF CLINICAL TRIALS TO DRIVE THE GROWTH OF THE MARKET (2017–2022)
Figure 9 SOFTWARE PLATFORMS TO DOMINATE THE GLOBAL CTMS MARKET TILL 2022
Figure 10 ENTERPRISE BASED CTMS PLATFORMS TO DOMINATE THE GLOBAL CTMS MARKET TILL 2022
Figure 11 WEB-BASED CTMS AND PHARMACEUTICAL COMPANIES TO DOMINATE THE CTMS MARKET IN 2017
Figure 12 CHINA TO BE THE FASTEST-GROWING MARKETS FOR CTMS DURING THE FORECAST PERIOD
Figure 13 MARKET DYNAMICS: DRIVER, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
Figure 14 GLOBAL INCREASE IN THE NUMBER OF CLINICAL TRIALS, 2002–2017
Figure 15 GLOBAL CTMS MARKET SHARE, BY TYPE, 2017 VS. 2022
Figure 16 ENTERPRISE CTMS MARKET SHARE, BY GEOGRAPHY (2017)
Figure 17 SITE CTMS MARKET SHARE, BY GEOGRAPHY (2017)
Figure 18 GLOBAL CTMS MARKET, BY MODE OF DELIVERY (2017 VS 2022)
Figure 19 WEB-BASED (ON-DEMAND) SEGMENT TO DOMINATE THE GLOBAL CTMS MARKET IN 2017
Figure 20 WEB-BASED (ON DEMAND) CTMS MARKET SHARE, BY REGION(2017)
Figure 21 LICENSED ENTERPRISE (ON-PREMISE) CTMS MARKET SHARE, BY REGION (2017)
Figure 22 CLOUD-BASED (SAAS) CTMS MARKET SHARE, BY REGION (2017)
Figure 23 SOFTWARE SEGMENT TO DOMINATE THE GLOBAL CTMS SOLUTIONS MARKET IN 2017
Figure 24 SOFTWARE MARKET SHARE, BY GEOGRAPHY (2017)
Figure 25 SERVICES MARKET SHARE, BY GEOGRAPHY (2017)
Figure 26 GLOBAL CTMS MARKET, BY END USER, 2017
Figure 27 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES SEGMENT TO DOMINATE THE GLOBAL CTMS MARKET IN 2017
Figure 28 R&D EXPENDITURE OF MAJOR PHARMACEUTICAL COMPANIES, 2015 VS. 2016 (USD MILLION)
Figure 29 PHARMACEUTICAL COMPANIES MARKET SHARE, BY GEOGRAPHY (2017)
Figure 30 LARGE PHARMACEUTICAL COMPANIES MARKET SHARE, BY GEOGRAPHY (2017)
Figure 31 MID-SMALL PHARAMCEUTICAL COMPANIES MARKET SHARE, BY GEOGRAPHY (2017)
Figure 32 CRO SERVICES COVER THE ENTIRE DRUG DEVELOPMENT SPECTRUM
Figure 33 CRO MARKET SHARE, BY GEOGRAPHY (2017)
Figure 34 MEDICAL DEVICE COMPANIES MARKET SHARE, BY GEOGRAPHY (2017)
Figure 35 OTHER END USERS MARKET SHARE, BY GEOGRAPHY (2017)
Figure 36 CTMS MARKET BY REGION (2017 VS 2022)
Figure 37 TOTAL NUMBER OF ONGOING CLINICAL TRIALS, BY REGION (DECEMBER 2017)
Figure 38 EUROPE: PHARMACEUTICAL R&D EXPENDITURE, BY COUNTRY, 2015 (USD MILLION)
Figure 39 KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE CTMS MARKET, 2014-2017
Figure 40 CTMS MARKET SHARE ANALYSIS, 2016
Figure 41 ORACLE: COMPANY SNAPSHOT
Figure 42 MEDIDATA SOLUTIONS: COMPANY SNAPSHOT
Figure 43 PAREXEL: COMPANY SNAPSHOT
Figure 44 IBM: COMPANY SNAPSHOT
Figure 45 DATATRAK: COMPANY SNAPSHOT
Figure 46 VEEVA SYSTEMS: COMPANY SNAPSHOT
Skip to top


Ask Your Question

Clinical Trial Management System Market by End User (Pharma & Biopharmaceutical Co., Medical Device Co., CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Services) - Global Forecast to 2022
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: